Dr. Wael Khreisat | Pediatrics | Best Researcher Award 

Dr. Wael Khreisat | Pediatrics | Neurologist at Royal Rehabilitation Center at Jordan

Pediatrics is the foundation of Dr. Wael Khreisat’s distinguished clinical and academic journey, defining his excellence in child neurological health, neurodevelopmental rehabilitation, and evidence-based diagnostic and therapeutic pediatric practices. As a highly dedicated Pediatric Neurologist serving at the esteemed Royal Rehabilitation Center in Jordan, Dr. Wael Khreisat has devoted his career to improving the clinical outcomes and quality of life of children suffering from complex neurological conditions, neurodevelopmental disorders, cerebral palsy, epilepsy, neuromuscular disorders, traumatic brain injuries, and behavioral neurodevelopmental disabilities. His professional identity blends deep medical expertise, compassionate patient care, and strong advocacy for early childhood neurological support, ensuring clinical interventions that improve long-term neurocognitive development. Dr. Wael Khreisat’s academic foundation is built upon rigorous medical education and specialized neurological training, culminating in pediatric subspecialization that has positioned him as one of Jordan’s leading experts in neuro-rehabilitation. His professional experience extends across outpatient and inpatient pediatric services, interdisciplinary rehabilitation programs, neuro-assessment clinics, and neurological diagnostics, bridging multidisciplinary teamwork and patient-centered therapeutic approaches. His research interest lies in pediatric neurology, clinical neurodevelopment, neurorehabilitation technologies, cerebral palsy management, neuroplasticity, and long-term outcomes of pediatric neurological interventions. He actively pursues research that investigates diagnostic innovations, neurological rehabilitation strategies, pediatric neurophysiology, and the integration of early rehabilitative therapy models, contributing to clinical protocols that are increasingly adopted across rehabilitation centers in the region. Throughout his medical career, Dr. Wael Khreisat has acquired core research, diagnostic, and clinical skills including EEG interpretation, neurological disorder assessment, rehabilitation program structuring, neurodevelopmental screening, clinical decision-making, and multidisciplinary therapeutic coordination. His dedication to academic pursuit has earned him recognition in scholarly communities and he has been honored with the Best Researcher Award, acknowledging the regional and clinical impact of his academic contributions in Pediatrics. Dr. Wael Khreisat has also contributed significantly to professional development within pediatric neurology through conference participation, case study reporting, and knowledge dissemination in interdisciplinary medical environments. His contributions emphasize holistic pediatric care, accurate clinical diagnosis, early interventions, functional rehabilitation, and psychosocial support tailored to child and family needs. As a pediatric neurologist integrated into a national rehabilitation center, his work reflects a compassionate commitment to children’s neurological health while advancing medical excellence across Jordan. Conclusively, Dr. Wael Khreisat represents a strong model of medical professionalism, scientific advancement, and community-centered healthcare practice in Pediatrics, consistently striving to deliver evidence-led treatments that elevate neurodevelopmental outcomes and empower families, rehabilitation teams, and the broader medical community.

Profile: ORCID

Featured Publications

1. Khreisat, W. (2024, December 11). An evaluation of whether routine QTc interval screening is necessary prior to starting ADHD medications: Experience from a large retrospective study. Pediatric Reports.

2. Khreisat, W. (2024, January 26). Atomoxetine treatment of attention deficit/hyperactivity disorder symptoms in 3–6-year-old children with autism spectrum disorder: A retrospective cohort study. Children (Basel, Switzerland).

3. Khreisat, W. (2022, July 19). The role of clinical pharmacist in pediatrics’ adherence to antiepileptic drugs. The Journal of Pharmacy Technology, 38(4), 256–263.

4. Khreisat, W. (2020, October). Genetic association of epilepsy and anti-epileptic drugs treatment in Jordanian patients. Pharmacogenomics and Personalized Medicine.

5. Khreisat, W. (2019, September). Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: A pharmacogenetic and case–control study. Pharmacogenomics and Personalized Medicine.

6. Khreisat, W. (2019, June). Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients. Pharmacogenomics and Personalized Medicine.

7. Khreisat, W. (2018). The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in Arab patients with epilepsy. Journal of Personalized Medicine, 8(4), 37.

8. Khreisat, W. (2011). Clinical applications of electroencephalogram in children. Basic and Clinical Neuroscience.